Add Yahoo as a preferred source to see more of our stories on Google. Roche has announced data from the open-label extension part of its Phase II trial of the BTK inhibitor. Image credit: Shutterstock ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Myelodysplastic syndromes (MDSs) are rare blood cancers in which your bone marrow overproduces abnormal, immature blood cells that crowd out healthy red blood cells, white blood cells, or platelets.